Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/1999
12/28/1999US6008367 Intermediate for synthesis of anticoagulant agents
12/28/1999US6008360 Cyclization
12/28/1999US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin
12/28/1999US6008350 Process for the production of cyanine dyes
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008235 Pyridyl substituted imidazoles
12/28/1999US6008234 Treating a human having a disease-state characterized by thrombotic activity, inhibiting human blood coagulation factor xa
12/28/1999US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999US6008223 Therapeutic compounds
12/28/1999US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/28/1999US6008204 Antidotes for preventing certain undesired side effects of retinoids
12/28/1999US6008161 Herbicidal 2-(hetero)aryloxy-6-arylpyridines and 2-aryl-4-(hetero) aryloxypyrimidines
12/28/1999US6008160 Substituted 1-amino-3-phenyluracil derivatives, their preparation and their use as herbicides
12/23/1999WO1999065898A1 Imidazolyl derivatives
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065896A1 Preparation of heteroaryl compounds
12/23/1999WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
12/23/1999WO1999065881A1 Heterocyclic compounds as hypoglycemic agents
12/23/1999WO1999065878A1 Synthesis of benzo[f]quinolinones
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065494A1 Inhibitors of prenyl-protein transferase
12/23/1999WO1999065487A1 Inhibitors of serotonin reuptake
12/23/1999WO1999065311A1 Composition for keeping away vermin
12/23/1999WO1999055156A3 The use of derivatives of iminotriazole as crop protection agents and novel iminotriazoles
12/23/1999WO1998054171A8 Novel form of s-omeprazole
12/23/1999WO1996002535A8 Process for synthesis of substituted sulphoxides
12/23/1999CA2335435A1 Imidazolyl derivatives
12/23/1999CA2335322A1 Inhibitors of serotonin reuptake
12/23/1999CA2334701A1 Synthesis of benzo¬f|quinolinones
12/23/1999CA2334677A1 Preparation of heteroaryl compounds
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2329932A1 Composition for keeping away vermin
12/22/1999EP0965589A1 Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
12/22/1999EP0965587A1 Tetrahydropyridinyl- and piperidinyl Inhibitors of serotonin reuptake
12/22/1999EP0964864A2 Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/22/1999EP0964860A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
12/22/1999EP0964859A1 New process
12/22/1999EP0964854A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964853A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964684A1 Crystalline pharmaceutical product
12/22/1999EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/22/1999EP0726893B1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
12/22/1999CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/22/1999CN1239435A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999CN1239093A Process for intermediates for manufacture of pyridine-2,3-dicarboxylate compounds
12/21/1999US6005106 Naphthalene derivatives, process for the preparation therof, and intermediates thereof
12/21/1999US6004993 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/21/1999US6004991 Compounds for cosmetics with enantiomorphs
12/21/1999US6004985 Thio acid derived monocylic N-heterocyclics as anticoagulants
12/21/1999US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999US6004979 Angiotensin ii inhibitors; 4-((carboxy)aryloxy)-quinoline derivatives
12/21/1999US6004977 N-(pyridinylamino) isoindolines and related compounds
12/21/1999US6004965 Endothelin inhibitors; hypotensive agents; cardiovascular disorders
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999US6004960 Pyridazinones as inhibitors of cyclooxygenase-2
12/21/1999US6004950 2-aminopyridines as inhibitors of cyclooxygenase-2
12/21/1999US6004531 Metal chelating compounds having an SNNN donor set
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/21/1999CA2006577C Hypoglycaemic phenylamidines and phenylguanidines
12/16/1999WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/16/1999WO1999064412A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999WO1999064411A1 Tetrahydroquinoline derivatives as glycine antagonists
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064399A1 Protease inhibitors
12/16/1999WO1999064396A1 Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands
12/16/1999WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/16/1999WO1999064392A1 Benzamidine derivative
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064011A1 Drugs
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors